To examine whether Konjac-mannan fiber improves metabolic control measured by glycemia, lipidemia, and blood pressure in individuals with type-2 diabetes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
11
Konjac-mannan fiber-enriched biscuits (0.7 g/412KJ \[100kcal\] of glucommanan)
Wheat bran (hard red wheat bran) fiber enriched biscuits
change in total:HDL cholesterol
Time frame: change from baseline at week 3, relative to control
change in fructosamine
Time frame: change from baseline at week 3, relative to control
change in systolic blood pressure
Time frame: change from baseline at week 3, relative to control
change in total cholesterol
Time frame: change from baseline at week 3, relative to control
change in LDL cholesterol
Time frame: change from baseline at week 3, relative to control
change in HDL cholesterol
Time frame: change from baseline at week 3, relative to control
change in apolipoprotein A-1
Time frame: change from baseline at week 3, relative to control
change in apolipoprotain B
Time frame: change from baseline at week 3, relative to control
change in glucose
Time frame: change from baseline at week 3, relative to control
change in insulin
Time frame: change from baseline at week 3, relative to control
diastolic blood pressure
Time frame: change from baseline at week 3, relative to control
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
change in body weight
Time frame: change from baseline at week 3, relative to control
change in apoB:ApoA-1
Time frame: change from baseline at week 3, relative to control